These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19842076)

  • 1. [Clinical experience with pegaptanib in the treatment of age-related macular degeneration (AMD)].
    Thelen U
    Klin Monbl Augenheilkd; 2010 Jan; 227(1):67-72. PubMed ID: 19842076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experience in the treatment of neovascular age-related macular degeneration with pegaptanib].
    Maier M; Feucht N; Huebner M; Lohmann C
    Klin Monbl Augenheilkd; 2008 Jun; 225(6):582-7. PubMed ID: 18516780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials.
    ; D'Amico DJ; Masonson HN; Patel M; Adamis AP; Cunningham ET; Guyer DR; Katz B
    Ophthalmology; 2006 Jun; 113(6):992-1001.e6. PubMed ID: 16647134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of naïve lesions in neovascular age-related macular degeneration with pegaptanib.
    Quiram PA; Hassan TS; Williams GA
    Retina; 2007 Sep; 27(7):851-6. PubMed ID: 17891008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of choroidal neovascularization following injection of pegaptanib sodium (macugen) in two eyes with neovascular age-related macular degeneration.
    Williams AJ; Fekrat S
    Am J Ophthalmol; 2006 Oct; 142(4):683-4. PubMed ID: 17011868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegaptanib for neovascular age-related macular degeneration.
    Gragoudas ES; Adamis AP; Cunningham ET; Feinsod M; Guyer DR;
    N Engl J Med; 2004 Dec; 351(27):2805-16. PubMed ID: 15625332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RPE tears after pegaptanib treatment in age-related macular degeneration.
    Chang LK; Flaxel CJ; Lauer AK; Sarraf D
    Retina; 2007 Sep; 27(7):857-63. PubMed ID: 17891009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
    Joeres S; Kaplowitz K; Brubaker JW; Updike PG; Collins AT; Walsh AC; Romano PW; Sadda SR
    Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
    ; Chakravarthy U; Adamis AP; Cunningham ET; Goldbaum M; Guyer DR; Katz B; Patel M
    Ophthalmology; 2006 Sep; 113(9):1508.e1-25. PubMed ID: 16828500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of intravitreal bevacizumab followed by pegaptanib maintenance as a treatment regimen for age-related macular degeneration.
    Hughes MS; Sang DN
    Ophthalmic Surg Lasers Imaging; 2006; 37(6):446-54. PubMed ID: 17152537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration.
    ; Apte RS; Modi M; Masonson H; Patel M; Whitfield L; Adamis AP
    Ophthalmology; 2007 Sep; 114(9):1702-12. PubMed ID: 17509689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pegaptanib sodium one-year treatment study for neovascular age-related macular degeneration].
    Tano Y;
    Nippon Ganka Gakkai Zasshi; 2008 Jul; 112(7):590-600. PubMed ID: 18702350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography findings during pegaptanib therapy for neovascular age-related macular degeneration.
    Emerson GG; Flaxel CJ; Lauer AK; Stout JT; Emerson MV; Nolte S; Wilson DJ; Klein ML
    Retina; 2007; 27(6):724-9. PubMed ID: 17621181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection.
    Hariprasad SM; Shah GK; Blinder KJ
    Am J Ophthalmol; 2006 Jan; 141(1):200-1. PubMed ID: 16387003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravitreal bevacizumab (Avastin) iniections for neovascular age-related macular degeneration (AMD)--preliminary results].
    Mackiewicz J; Mańkowska A; Dolar-Szczasny J; Zubilewicz A; Oleszczuk A; Nowomiejska K; Rejdak R; Zagórski Z
    Klin Oczna; 2007; 109(4-6):146-9. PubMed ID: 17725273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
    Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.
    Adamis AP; Altaweel M; Bressler NM; Cunningham ET; Davis MD; Goldbaum M; Gonzales C; Guyer DR; Barrett K; Patel M;
    Ophthalmology; 2006 Jan; 113(1):23-8. PubMed ID: 16343627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Predictors for Good Versus Poor Visual Outcomes in the Treatment of Neovascular Age-Related Macular Degeneration With Intravitreal Anti-VEGF Therapy.
    Chae B; Jung JJ; Mrejen S; Gallego-Pinazo R; Yannuzzi NA; Patel SN; Chen CY; Marsiglia M; Boddu S; Freund KB
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5040-7. PubMed ID: 26237196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early response of retinal angiomatous proliferation treated with intravitreal pegaptanib: a retrospective review.
    Mahmood S; Kumar N; Lenfestey PM; Murjaneh S; Heimann H; Harding SP
    Eye (Lond); 2009 Mar; 23(3):530-5. PubMed ID: 18425070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of neovascular age-related macular degeneration with intravitreal vascular endothelial growth factor inhibitor--secondary publication].
    Larsen M; Sander B; Villumsen JE; Haamann PH; la Cour M; Lund-Andersen H;
    Ugeskr Laeger; 2005 Aug; 167(35):3301-5. PubMed ID: 16138974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.